155 related articles for article (PubMed ID: 20391865)
1. Prevalence of metabolic syndrome among an Iranian cohort of inpatients with schizophrenia.
Rezaei O; Khodaie-Ardakani MR; Mandegar MH; Dogmehchi E; Goodarzynejad H
Int J Psychiatry Med; 2009; 39(4):451-62. PubMed ID: 20391865
[TBL] [Abstract][Full Text] [Related]
2. The reliability of the National Cholesterol Education Program's Adult Treatment Panel III (NCEP/ATP III) and the International Diabetes Federation (IDF) definitions in diagnosing metabolic syndrome (MetS) among Gaza Strip Palestinians.
Sirdah MM; Abu Ghali AS; Al Laham NA
Diabetes Metab Syndr; 2012; 6(1):4-8. PubMed ID: 23014247
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of metabolic syndrome among inpatients with schizophrenia.
Boke O; Aker S; Sarisoy G; Saricicek EB; Sahin AR
Int J Psychiatry Med; 2008; 38(1):103-12. PubMed ID: 18624022
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of vascular disease in metabolic syndrome using three proposed definitions.
Athyros VG; Ganotakis ES; Elisaf MS; Liberopoulos EN; Goudevenos IA; Karagiannis A;
Int J Cardiol; 2007 Apr; 117(2):204-10. PubMed ID: 16854482
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication.
De Hert MA; van Winkel R; Van Eyck D; Hanssens L; Wampers M; Scheen A; Peuskens J
Schizophr Res; 2006 Mar; 83(1):87-93. PubMed ID: 16481149
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome among psychiatric inpatients with schizophrenia in Indonesia.
Marthoenis M; Aichberger MC; Puteh I; Syahrial S; Schouler-Ocak M
Asian J Psychiatr; 2015 Jun; 15():10-4. PubMed ID: 25910596
[TBL] [Abstract][Full Text] [Related]
7. Prognostic interactions between cardiovascular risk factors.
Vishram JK
Dan Med J; 2014 Jul; 61(7):B4892. PubMed ID: 25123126
[TBL] [Abstract][Full Text] [Related]
8. A two fold risk of metabolic syndrome in a sample of patients with schizophrenia: do consanguinity and family history increase risk?
Bener A; Al-Hamaq AO; Dafeeah EE
Diabetes Metab Syndr; 2014; 8(1):24-9. PubMed ID: 24661754
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder.
van Winkel R; De Hert M; Van Eyck D; Hanssens L; Wampers M; Scheen A; Peuskens J
Bipolar Disord; 2008 Mar; 10(2):342-8. PubMed ID: 18271914
[TBL] [Abstract][Full Text] [Related]
10. Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population.
Athyros VG; Ganotakis ES; Tziomalos K; Papageorgiou AA; Anagnostis P; Griva T; Kargiotis K; Mitsiou EK; Karagiannis A; Mikhailidis DP
Curr Med Res Opin; 2010 Mar; 26(3):713-9. PubMed ID: 20078335
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of metabolic syndrome and Framingham cardiovascular risk scores in adult inpatients taking antipsychotics - a retrospective medical records review.
Wysokiński A; Kowman M; Kłoszewska I
Psychiatr Danub; 2012 Sep; 24(3):314-22. PubMed ID: 23013638
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of metabolic syndrome among patients with schizophrenia in Japan.
Sugawara N; Yasui-Furukori N; Sato Y; Umeda T; Kishida I; Yamashita H; Saito M; Furukori H; Nakagami T; Hatakeyama M; Nakaji S; Kaneko S
Schizophr Res; 2010 Nov; 123(2-3):244-50. PubMed ID: 20850274
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of metabolic syndrome and its association with alanine aminotransferase in clozapine-treated Korean patients with schizophrenia.
Lee NY; Roh MS; Kim SH; Jung DC; Yu HY; Sung KH; Chung IW; Youn T; Kang UG; Ahn YM; Kim YS
Int Clin Psychopharmacol; 2013 Mar; 28(2):71-9. PubMed ID: 23211493
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a population-based study.
Bener A; Zirie M; Musallam M; Khader YS; Al-Hamaq AO
Metab Syndr Relat Disord; 2009 Jun; 7(3):221-9. PubMed ID: 19320557
[TBL] [Abstract][Full Text] [Related]
15. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome.
Cussons AJ; Watts GF; Burke V; Shaw JE; Zimmet PZ; Stuckey BG
Hum Reprod; 2008 Oct; 23(10):2352-8. PubMed ID: 18635531
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of metabolic syndrome in pre- and postmenopausal Iranian women.
Maharlouei N; Bellissimo N; Ahmadi SM; Lankarani KB
Climacteric; 2013 Oct; 16(5):561-7. PubMed ID: 23157491
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular risk and prevalence of metabolic syndrome by differing criteria.
Li WJ; Xue H; Sun K; Song XD; Wang YB; Zhen YS; Han YF; Hui RT
Chin Med J (Engl); 2008 Aug; 121(16):1532-6. PubMed ID: 18985935
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of the metabolic syndrome in schizophrenic patients receiving second-generation antipsychotic agents--a cross-sectional study.
Kagal UA; Torgal SS; Patil NM; Malleshappa A
J Pharm Pract; 2012 Jun; 25(3):368-73. PubMed ID: 22551560
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of metabolic syndrome according to different definitions in a hypertensive population.
Lioudaki E; Vrentzos GE; Mavrogeni H; Zeniodi MH; Ganotakis ES; Mikhailidis DP; Papadakis JA
Angiology; 2012 Jan; 63(1):39-47. PubMed ID: 21555311
[TBL] [Abstract][Full Text] [Related]
20. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
